Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 10Gastrointestinal 6Head & Neck 5Thoracic 3Sarcoma 2Lymphoid 2Classical hematology 2Other hematologic neoplasm 1Gynecologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Lymphoma 309Lymphoma, Non-Hodgkin 227Lymphoma, Large B-Cell, Diffuse 223Lymphoma, Follicular 203Leukemia, Lymphocytic, Chronic, B-Cell 168Lymphoma, B-Cell 150Recurrence 130Burkitt Lymphoma 120Lymphoma, Mantle-Cell 115Leukemia, Myeloid, Acute 106Hodgkin Disease 102Leukemia 101Multiple Myeloma 95Lymphoma, B-Cell, Marginal Zone 88Neoplasms 81Myelodysplastic Syndromes 69Lymphoma, T-Cell, Peripheral 64Hematologic Neoplasms 61Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58Lymphoma, T-Cell 51Lymphoma, T-Cell, Cutaneous 44Waldenstrom Macroglobulinemia 42Leukemia, Biphenotypic, Acute 35Mycosis Fungoides 32Lymphoproliferative Disorders 30Leukemia, B-Cell 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Breast Neoplasms 28Myeloproliferative Disorders 26

Interventions

Observation 1Methotrexate 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Pathologic Complete Response × Lymphoid × Clear all
NCT07353840 2026-01-20

T-START-CR

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Recruiting
160 enrolled
Lymphoid

Pathologic Complete Response, Lymphoma, T-Cell, Peripheral

NCT04314219 2025-03-13

PTCy-PMAT

King Faisal Specialist Hospital & Research Center

Phase 3 Recruiting
264 enrolled
LymphoidOther hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡